Recent publications · Crossref
5 total works indexed
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
· 2017 · cited 2,015x
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
· 2018 · cited 1,710x
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
· 2018 · cited 1,548x
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
· 2002 · cited 1,476x
- Preexposure Prophylaxis for HIV Infection among African Women
· 2012 · cited 1,370x
via Crossref · CC0